Home › Funds › SECTOR GAMMA AS › CYTK

SECTOR GAMMA AS position in CYTK

CYTOKINETICS INC · Health Care

SECTOR GAMMA AS reported holding 45,000 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 0.61% of its reported portfolio and ranking #38 among its reported holdings. SECTOR GAMMA AS has disclosed CYTK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)45.00K sh
Reported value held$2.97M
Portfolio Weight0.61%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SECTOR GAMMA AS's CYTK position evolved

SECTOR GAMMA AS first disclosed a stake in CYTK in Q2 2026 at 45,000 shares (US$3.8M). Across 2 filings, SECTOR GAMMA AS held the position steady without any share-count change. The most recent filing (Q3 2026) shows 45,000 shares valued at US$3.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 45.00K $3.83M New
Q3 2026 45.00K $2.97M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 44 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has SECTOR GAMMA AS held CYTK?

SECTOR GAMMA AS has disclosed CYTK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is SECTOR GAMMA AS's current position in CYTK?

As of Q3 2026, SECTOR GAMMA AS holds 45.00K shares of CYTK (CYTOKINETICS INC), valued at $2.97M, representing 0.61% of its reported portfolio and ranking #38.

Has SECTOR GAMMA AS been buying or selling CYTK?

In the latest 13F filing (Q3 2026), SECTOR GAMMA AS held unchanged its position in CYTK.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.